Literature DB >> 15026112

Endothelin B receptor deficient transgenic rescue rats: a rescue phenomenon in the brain.

C-C Riechers1, W Knabe, A-L Sirén, C E Gariepy, M Yanagisawa, H Ehrenreich.   

Abstract

Homozygous endothelin B receptor deficiency leads to congenital aganglionosis of the gut in rats and mice, equivalent to human Hirschsprung disease. Homozygous endothelin B receptor deficient rats (spotting lethal rats, sl/sl) are characterized not only by this developmental disorder of the enteric nervous system, which limits their life span to 3-4 weeks, but exhibit an increased rate of apoptosis in the dentate gyrus compared to wildtype (+/+) rats. Recently, endothelin B receptor deficient transgenic rescue rats (sl/sl, tg/tg) were created to further investigate the role of the endothelin B receptor in mature animals. Linkage of the human dopamine-beta-hydroxylase promoter to the rat endothelin B receptor gene and expression of this transgenic construct results in normal development of the enteric nervous system. We investigated the expression pattern of this transgenic construct in the brain by using reverse transcriptase polymerase chain reaction. Unexpectedly, transgene mRNA expression was not restricted to the brain stem where adrenergic and noradrenergic nuclei are known to be present but, in addition, was also detectable in hippocampus and cortex. Using in situ tailing technique, cleaved caspase-3 immunohistochemistry and analysis of hematoxylin-eosin-stained serial sections, we found that all studied transgenic animals were rescued from the increased rate of apoptosis in the dentate gyrus characteristic for non-transgenic sl/sl rats. This finding supports our previous observation that the endothelin B receptor might be an important regulatory element supporting cellular survival in the hippocampus during postnatal development. The endothelin B receptor deficient transgenic rescue rats used here are rescued from developmental disorders both in the gut and in the brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026112     DOI: 10.1016/j.neuroscience.2003.10.023

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

1.  Hippocampal cannabinoid-1 receptor upregulation upon endothelin-B receptor deficiency: a neuroprotective substitution effect?

Authors:  Christian Unzicker; Heike Erberich; Gabriella Moldrich; Helge Woldt; Jan Bulla; Raphael Mechoulam; Hannelore Ehrenreich; Anna-Leena Sirén
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

2.  Mechanism of Rho-kinase-mediated Ca2+-independent contraction in aganglionic smooth muscle in a rat model of Hirschsprung's disease.

Authors:  Junko Akiyoshi; Satoshi Ieiri; Takanori Nakatsuji; Tomoaki Taguchi
Journal:  Pediatr Surg Int       Date:  2009-11       Impact factor: 1.827

3.  Deficiency in endothelin receptor B reduces proliferation of neuronal progenitors and increases apoptosis in postnatal rat cerebellum.

Authors:  Maria Vidovic; Ming-Ming Chen; Qun-Ying Lu; Katherine F Kalloniatis; Ben M Martin; Abel H Y Tan; Celina Lynch; G David H Croaker; Daniel T Cass; Zan-Min Song
Journal:  Cell Mol Neurobiol       Date:  2008-08-06       Impact factor: 5.046

4.  Stromal endothelin B receptor-deficiency inhibits breast cancer growth and metastasis.

Authors:  Claudia Binder; Thorsten Hagemann; Swetlana Sperling; Matthias Schulz; Tobias Pukrop; Matthew J Grimshaw; Hannelore Ehrenreich
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

Review 5.  Endothelin Receptors, Mitochondria and Neurogenesis in Cerebral Ischemia.

Authors:  Anil Gulati
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

6.  Sovateltide (IRL-1620) activates neuronal differentiation and prevents mitochondrial dysfunction in adult mammalian brains following stroke.

Authors:  Amaresh K Ranjan; Seema Briyal; Anil Gulati
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

7.  Anti-apoptotic activity of ETB receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia.

Authors:  Seema Briyal; Amaresh K Ranjan; Mary G Hornick; Anupama K Puppala; Thanh Luu; Anil Gulati
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379

8.  Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke.

Authors:  Anil Gulati; Nilesh Agrawal; Deepti Vibha; U K Misra; Birinder Paul; Dinesh Jain; Jeyaraj Pandian; Rupam Borgohain
Journal:  CNS Drugs       Date:  2021-01-11       Impact factor: 5.749

9.  Central Sympathetic Activation and Arrhythmogenesis during Acute Myocardial Infarction: Modulating Effects of Endothelin-B Receptors.

Authors:  Theofilos M Kolettis; Marianthi Kontonika; Eleonora Barka; Evangelos P Daskalopoulos; Giannis G Baltogiannis; Christos Tourmousoglou; Apostolos Papalois; Zenon S Kyriakides
Journal:  Front Cardiovasc Med       Date:  2015-02-23

Review 10.  Sovateltide Mediated Endothelin B Receptors Agonism and Curbing Neurological Disorders.

Authors:  Amaresh K Ranjan; Anil Gulati
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.